We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:BBOT
​
​
logo

BridgeBio Oncology Therapeutics (BBOT)

Nasdaq • BBOT • US1079241022

2.30Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 26, 2026, ORTEX estimated 10.8% of free float sold short, 6.5 days to cover, cost to borrow 1.04%. Sign up for live short interest data.

Market Cap

184m USD | # 7587 in US

Volume

570.27k shares | 3.04m USD

Shares Outstanding

80.17m

Free Float Shares

44.67% | 35.81m

News

BBOT key data

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) has a market capitalization of $184.4M. Last close $2.30 (as of 2026-11-10); 52-week range $1.98 to $14.87. ORTEX data as of 2026-10-26: short interest was 10.75% of free float, 6.5 days to cover and the average cost to borrow was 1.04%. Sign up for live short interest data.

  • BBOT news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.